poisar

Stocks · News reference

NuScale And Oklo Heat Up, These Leveraged Nuclear ETFs Are Soaring Past 30%

BenzingaChandrima Sanyal

ETFs tied to NuScale surged more than 30% Tuesday as renewed investor interest in nuclear energy sent SMR, Oklo shares higher.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolDavid Jagielski, Cpa

    Oklo Stock Hits a New 52-Week Low: Time to Buy?

    Oklo (OKLO) stock has plummeted 55% this year and hit a new 52-week low of $31, despite potential growth opportunities in AI data center power solutions. However, the company faces significant challenges: it won't generate meaningful revenue until late 2025 when its Aurora facility begins operations, operating losses have more than doubled to $124.2 million in the first half of 2026, and its $6 billion valuation remains high for an early-stage company. Analysts suggest the stock remains too risky for most investors and could fall further.

  2. The Motley FoolSteven Porrello

    Is Oklo Stock Your Ticket to Becoming a Millionaire?

    Oklo is developing small nuclear reactors to power AI data centers and reduce fossil fuel dependence. While the company has secured support from Meta and other tech companies, it remains highly speculative with no commercial reactors deployed yet. For investors to become millionaires, the stock would need to gain 100-fold, making it an unrealistic expectation given the company's current stage and regulatory hurdles.

  3. The Motley FoolReuben Gregg Brewer

    NuScale Power Trades Near $8. Here's What Has to Happen for It to See $20 Again.

    NuScale Power's stock has plummeted 85% from its $53 peak to under $8, driven by investor sentiment swings rather than business fundamentals. The company, which develops small modular nuclear reactors (SMRs), has an approved design but hasn't secured its first commercial customer yet. A signed contract with RoPower or participation in major U.S. nuclear deployment programs could be the catalyst to push the stock toward $20, though the company remains a high-risk startup with significant execution risks ahead.